Loading patent…
AssigneeSociete des Produits Nestle S.A.
InventorsLucas Actis Goretta, Jacklyn Ruilin Chen, Rachid Bel-Rhlid, Robin Willows, Marine Kraus, Christian Chabert
Estimating the term…
The present invention relates to a green coffee-based composition comprising hydrolysed chlorogenic acid for use in the treatment or prevention of a disorder linked to an increase in plasma postprandial insulin in a subject. The invention relates also to the non-therapeutic use of a composition comprising an esterase treated decaffeinated green coffee extract with an amount of 40-200 mg administered to a subject per day to decrease plasma postprandial insulin concentration. A further aspect of the invention is a process for forming green coffee based compositions.
A method for treating an increase in a plasma postprandial insulin concentration in a subject in need thereof, the method comprising administering to the subject as part of or at the end of a regular meal an effective dose of esterase treated decaffeinated green coffee extract with an amount of 40-200 mg/day, wherein the effective dose of esterase treated decaffeinated green coffee extract decreases the plasma postprandial insulin concentration in the subject.
Dependencies are inferred from the claim text.